Concepedia
Statistics
Publications
19
Citations
674
H-Index
14
Active since
2013
Affiliations
University of British Columbia(Current)
Johannes Gutenberg University Mainz
Vancouver General Hospital
The Prostate Centre
University of Copenhagen
Igor Moskalev is an author at University of British Columbia specializing in medicine, oncology, and bladder cancer.
Publications per year
2013–2023
Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer
Tetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo et al. · The Journal of Urology · 2015 · 84 citations
Medicine, Oncology, Pharmacology +17
Local checkpoint inhibition of CTLA‐4 as a monotherapy or in combination with anti‐PD1 prevents the growth of murine bladder cancer
Luuk van Hooren, Linda C. Sandin, Igor Moskalev et al. · European Journal of Immunology · 2016 · 75 citations · Full text
Medicine, Immunology, Oncology +17
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer
Tilman Todenhöfer, Roland Seiler, Igor Moskalev et al. · Molecular Cancer Therapeutics · 2018 · 72 citations
Medicine, Cancer Biology, Oncology +15
Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach
Wolfgang Jäger, Igor Moskalev, Tetsutaro Hayashi et al. · PLoS ONE · 2013 · 55 citations · Full text
Medicine, Oncology, Pharmacology +13
Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells
Kevin J. Tam, Daniel H. Hui, Wilson W. Lee et al. · Scientific Reports · 2017 · 55 citations · Full text
Medicine, Cancer Biology, Molecular Biology +17
1–5 of 19